GlassScriptPhysician profile
Brandi Langdon
NPI 1962402867
$3,431.85
in general payments reported to CMS, 2019-2025
35 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $688 · 2022: $685 · 2023: $1,054 · 2024: $615 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,059.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $635.61 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $406.64 | 2021-2024 | Xifaxan, Plenvu |
| Novartis Pharmaceuticals Corporation | $344.97 | 2022-2025 | |
| Amgen INC. | $261.98 | 2021-2025 | Prolia, Evenity, Repatha |
| Pfizer INC. | $193.32 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $157.65 | 2021-2023 | Xarelto |
| Evoke Pharma, INC. | $155.02 | 2022-2025 | Gimoti |
| Abbott Laboratories | $121.97 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $105.69 | 2022-2024 | Shingrix |
| Dexcom, INC. | $88.54 | 2022-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $80.78 | 2021-2024 | Jardiance, Zepbound, Emgality |
| Eisai INC. | $80.29 | 2021-2025 | |
| Genzyme Corporation | $70.89 | 2023-2024 | |
| Corcept Therapeutics | $70.61 | 2025 | Korlym |
| Janssen Biotech, INC. | $65.50 | 2021-2023 | Stelara |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $64.12 | 2021 | |
| Novo Nordisk INC | $58.29 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.46 | 2024-2025 | Ofev |
| Exact Sciences Corporation | $49.76 | 2025 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $44.90 | 2021-2023 | Suflave, Sutab |
| Regeneron Healthcare Solutions, INC. | $41.13 | 2024 | Dupixent |
| Alnylam Pharmaceuticals INC. | $40.60 | 2021 | |
| Merck Sharp & Dohme LLC | $40.52 | 2021-2025 | Capvaxive, Gardasil 9 |
| Amarin Pharma, INC. | $27.83 | 2021 | |
| United Therapeutics Corporation | $24.53 | 2025 | Tyvaso |
| Boston Scientific Corporation | $21.03 | 2024 | Watchman Flx |
| Almatica Pharma LLC | $20.78 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $17.07 | 2025 | Voquezna |
| Philips North America LLC | $14.62 | 2024 | (Ck4) Mcot |
| Astellas Pharma US INC | $13.80 | 2024 | Veozah |
| Esperion Therapeutics, INC. | $13.11 | 2021 | |
| Nevro Corp. | $13.07 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.87 | 2022 | |
| Organon LLC | $5.90 | 2023 | Renflexis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Langdon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.